Symposia ProgrammeMTE SessionsSponsorsBecome a sponsor
Helen Colhoun
Thursday
18:30-20:00
Ehrlich Hall
High CV risk populations who may benefit the most from PCSK9i therapy: highlights from the most recent ODYSSEY OUTCOMES data
Ulrich Laufs
Legal NoticeData Protection